SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Cases of de novo immune thrombocytopenia (ITP), including a fatality, following SARS-CoV-2 vaccination in previously healthy recipients led to studying its impact in preexisting ITP. In this study, 4 data sources were analyzed: the Vaccine Adverse Events Reporting System (VAERS) for cases of de novo...

Full description

Bibliographic Details
Main Authors: Al-Samkari, H. (Author), Beltrami-Moreira, M. (Author), Bussel, J.B (Author), Cines, D.B (Author), Cuker, A. (Author), DiRaimo, J. (Author), Gernsheimer, T. (Author), Kessler, C. (Author), Kruse, A. (Author), Kruse, C. (Author), Kuter, D.J (Author), Leavitt, A.D (Author), Lee, A.I (Author), Lee, E.-J (Author), Liebman, H.A (Author), Newland, A.C (Author), Ray, A.E (Author), Tarantino, M.D (Author), Thachil, J. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
ad26.cov2.s vaccine
administration and dosage
adult
adverse event
adverse outcome
aged
Aged
Aged, 80 and over
antiphospholipid syndrome
Article
autoimmune disease
autoimmune hemolytic anemia
autoimmune thrombocytopenia
azathioprine
bleeding
blood
Blood Platelets
brain hemorrhage
British citizen
central nervous system
clinical trial
comorbidity
controlled study
coronavirus disease 2019
corticosteroid
COVID-19
COVID-19 Vaccines
cyclosporine
dapsone
disease course
disease exacerbation
drug safety
elasomeran
eltrombopag
female
Female
gastrointestinal hemorrhage
human
Humans
ibrutinib
idiopathic thrombocytopenic purpura
immunoglobulin
immunology
incidence
major clinical study
male
Male
medical history
metabolism
middle aged
Middle Aged
mouth mucosa
multicenter study
mycophenolate mofetil
patient monitoring
platelet count
prediction
prevention and control
Purpura, Thrombocytopenic, Idiopathic
register
repeated drug dose
Retrospective Studies
retrospective study
risk factor
Risk Factors
rituximab
RNA vaccine
romiplostim
SARS-CoV-2
SARS-CoV-2 vaccine
Severe acute respiratory syndrome coronavirus 2
skin
skin bleeding
splenectomy
Splenectomy
subarachnoid hemorrhage
subdural hematoma
symptom
thrombocyte
thrombocyte transfusion
thrombocytopenia
tozinameran
treatment response
United Kingdom
urogenital system
vaccination
vaxzevria
very elderly
vincristine
warfarin
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items